Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1268

1.

Symptomatic remission and social/vocational functioning in outpatients with schizophrenia: prevalence and associations in a cross-sectional study.

San L, Ciudad A, Alvarez E, Bobes J, Gilaberte I.

Eur Psychiatry. 2007 Nov;22(8):490-8. Epub 2007 Sep 27.

PMID:
17904337
2.

[Social outcome of schizophrenics in Tunisia: a transversal study of 60 patients].

Rafrafi R, Zaghdoudi L, Mahbouli M, Bouzid R, Labbane R, El Hechmi Z.

Encephale. 2009 Jun;35(3):234-40. doi: 10.1016/j.encep.2008.05.001. Epub 2008 Sep 23. French.

PMID:
19540409
3.

Experiences of victimisation and depression are associated with community functioning among men with schizophrenia.

Hodgins S, Lincoln T, Mak T.

Soc Psychiatry Psychiatr Epidemiol. 2009 Jun;44(6):448-57. doi: 10.1007/s00127-008-0460-8. Epub 2008 Nov 22.

PMID:
19030767
4.

Correlates of subjective and functional outcomes in outpatient clinic attendees with schizophrenia and schizoaffective disorder.

Hofer A, Rettenbacher MA, Widschwendter CG, Kemmler G, Hummer M, Fleischhacker WW.

Eur Arch Psychiatry Clin Neurosci. 2006 Jun;256(4):246-55. Epub 2005 Nov 29.

PMID:
16311896
5.

[Evolution of the social autonomy scale (EAS) in schizophrenic patients depending on their management].

Leguay D, Rouillon F, Azorin JM, Gasquet I, Loze JY, Arnaud R, Dillenschneider A.

Encephale. 2010 Oct;36(5):397-407. doi: 10.1016/j.encep.2010.01.004. Epub 2010 Mar 11. French.

PMID:
21035630
6.

Outcome and its predictors in schizophrenia within the Northern Finland 1966 Birth Cohort.

Lauronen E, Miettunen J, Veijola J, Karhu M, Jones PB, Isohanni M.

Eur Psychiatry. 2007 Mar;22(2):129-36. Epub 2006 Nov 28.

PMID:
17129711
7.

Prognostic value of cognitive functioning for global functional recovery in first-episode schizophrenia.

González-Blanch C, Perez-Iglesias R, Pardo-García G, Rodríguez-Sánchez JM, Martínez-García O, Vázquez-Barquero JL, Crespo-Facorro B.

Psychol Med. 2010 Jun;40(6):935-44. doi: 10.1017/S0033291709991267. Epub 2009 Sep 15.

PMID:
19751542
8.

Substance abuse and cognitive functioning in schizophrenia.

Addington J, Addington D.

J Psychiatry Neurosci. 1997 Mar;22(2):99-104.

9.

A pilot study of barriers to medication adherence in schizophrenia.

Hudson TJ, Owen RR, Thrush CR, Han X, Pyne JM, Thapa P, Sullivan G.

J Clin Psychiatry. 2004 Feb;65(2):211-6.

PMID:
15003075
10.

Evaluation of factors influencing medication compliance in inpatient treatment of psychotic disorders.

Janssen B, Gaebel W, Haerter M, Komaharadi F, Lindel B, Weinmann S.

Psychopharmacology (Berl). 2006 Aug;187(2):229-36. Epub 2006 May 19.

PMID:
16710714
11.

The concepts of remission and recovery in schizophrenia.

Leucht S, Lasser R.

Pharmacopsychiatry. 2006 Sep;39(5):161-70. Review.

PMID:
16944406
12.

Attitudes of schizophrenia outpatients toward psychiatric medications: relationship to clinical variables and insight.

Freudenreich O, Cather C, Evins AE, Henderson DC, Goff DC.

J Clin Psychiatry. 2004 Oct;65(10):1372-6.

PMID:
15491241
13.

Violence among schizophrenia out-patients compliant with medication: prevalence and associated factors.

Bobes J, Fillat O, Arango C.

Acta Psychiatr Scand. 2009 Mar;119(3):218-25. doi: 10.1111/j.1600-0447.2008.01302.x.

PMID:
19178395
14.

Symptomatic remission in previously untreated patients with schizophrenia: 2-year results from the SOHO study.

Novick D, Haro JM, Suarez D, Lambert M, Lépine JP, Naber D.

Psychopharmacology (Berl). 2007 May;191(4):1015-22. Epub 2007 Feb 20.

PMID:
17310386
15.
16.

[Quality of life in patients with schizophrenia: a study of 100 cases].

Zouari L, Thabet JB, Elloumi Z, Elleuch M, Zouari N, Maâlej M.

Encephale. 2012 Apr;38(2):111-7. doi: 10.1016/j.encep.2011.03.005. Epub 2011 May 25. French.

PMID:
22516268
17.

[Schizophrenia diagnostic announcement in a French psychiatric unit].

Rocamora JF, Benadhira R, Saba G, Stamatadis L, Kalalaou K, Dumortier G, Plaze M, Aubriot-Delmas B, Glikman J, Januel D.

Encephale. 2005 Jul-Aug;31(4 Pt 1):449-55. French.

PMID:
16389712
18.

Remission in schizophrenia: results from a 1-year follow-up observational study.

Ciudad A, Alvarez E, Bobes J, San L, Polavieja P, Gilaberte I.

Schizophr Res. 2009 Mar;108(1-3):214-22. doi: 10.1016/j.schres.2008.12.004. Epub 2009 Jan 24.

PMID:
19168329
19.

Treatment response in psychotic patients classified according to social and clinical needs, drug side effects, and previous treatment; a method to identify functional remission.

Alenius M, Hammarlund-Udenaes M, Hartvig P, Sundquist S, Lindström L.

Compr Psychiatry. 2009 Sep-Oct;50(5):453-62. doi: 10.1016/j.comppsych.2008.11.001. Epub 2009 Jan 16.

PMID:
19683616
20.

Treatment compliance of outpatients with schizophrenia: patient's attitudes, demographic, clinical and therapeutic variables.

Stanković Z, Britvić D, Vuković O, Ille T.

Psychiatr Danub. 2008 Mar;20(1):42-52.

PMID:
18376330

Supplemental Content

Support Center